Trial Profile
A Real World Study Assessing the Safety and Effectiveness of Secukinumab in Patients with Plaque-Psoriasis and Psoriatic-Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2017
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary)
- Indications Plaque psoriasis; Psoriatic arthritis
- Focus Adverse reactions; Therapeutic Use
- 08 Jun 2017 New trial record
- 07 Mar 2017 Trial design presented at the 75th Annual Meeting of the American Academy of Dermatology.